CN1613874A - 全人源肿瘤坏死因子抗体,其制备方法以及药物组合物 - Google Patents
全人源肿瘤坏死因子抗体,其制备方法以及药物组合物 Download PDFInfo
- Publication number
- CN1613874A CN1613874A CN 200310108440 CN200310108440A CN1613874A CN 1613874 A CN1613874 A CN 1613874A CN 200310108440 CN200310108440 CN 200310108440 CN 200310108440 A CN200310108440 A CN 200310108440A CN 1613874 A CN1613874 A CN 1613874A
- Authority
- CN
- China
- Prior art keywords
- antibody
- tnf
- sequence
- cell
- ser
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
细胞株 | 2A4 | 3H2 | 4A6 | 5D5 | 7B3 | 4H7 |
表达量 | 253.6 | 167.9 | 239.9 | 147.9 | 289.8 | 177.5 |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2003101084400A CN100393748C (zh) | 2003-11-06 | 2003-11-06 | 全人源肿瘤坏死因子抗体,其制备方法以及药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2003101084400A CN100393748C (zh) | 2003-11-06 | 2003-11-06 | 全人源肿瘤坏死因子抗体,其制备方法以及药物组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1613874A true CN1613874A (zh) | 2005-05-11 |
CN100393748C CN100393748C (zh) | 2008-06-11 |
Family
ID=34758595
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2003101084400A Withdrawn - After Issue CN100393748C (zh) | 2003-11-06 | 2003-11-06 | 全人源肿瘤坏死因子抗体,其制备方法以及药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100393748C (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008141511A1 (fr) * | 2007-05-22 | 2008-11-27 | Human Antibodomics (Shanghai) Inc. | ANTICORPS MONOCLONAL HUMAIN ANTI-TNFα ET SON UTILISATION |
WO2010105446A1 (zh) * | 2009-03-20 | 2010-09-23 | 上海宏源生物技术有限公司 | 抗人肿瘤坏死因子受体α单抗及其应用 |
WO2011085574A1 (zh) * | 2010-01-15 | 2011-07-21 | 苏州工业园区晨健抗体组药物开发有限公司 | 全人TNFα单克隆抗体及其制备方法与应用 |
CN102167741A (zh) * | 2010-02-25 | 2011-08-31 | 百迈博药业有限公司 | 一种全人源抗TNF-α单克隆抗体、其制备方法及用途 |
CN101684156B (zh) * | 2008-09-27 | 2011-12-28 | 苏州工业园区晨健抗体组药物开发有限公司 | 人TNFα单克隆抗体、其PEG化纳米颗粒及其应用 |
CN101696243B (zh) * | 2009-10-27 | 2012-05-16 | 中国人民解放军军事医学科学院卫生学环境医学研究所 | 人源基因工程抗体trd109及其制备方法与应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0013810D0 (en) * | 2000-06-06 | 2000-07-26 | Celltech Chiroscience Ltd | Biological products |
-
2003
- 2003-11-06 CN CNB2003101084400A patent/CN100393748C/zh not_active Withdrawn - After Issue
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008141511A1 (fr) * | 2007-05-22 | 2008-11-27 | Human Antibodomics (Shanghai) Inc. | ANTICORPS MONOCLONAL HUMAIN ANTI-TNFα ET SON UTILISATION |
CN101684156B (zh) * | 2008-09-27 | 2011-12-28 | 苏州工业园区晨健抗体组药物开发有限公司 | 人TNFα单克隆抗体、其PEG化纳米颗粒及其应用 |
WO2010105446A1 (zh) * | 2009-03-20 | 2010-09-23 | 上海宏源生物技术有限公司 | 抗人肿瘤坏死因子受体α单抗及其应用 |
US8354108B2 (en) | 2009-03-20 | 2013-01-15 | Qingfa Liu | Fully human antibody to human TNFα, molecular evolution and use thereof |
CN101696243B (zh) * | 2009-10-27 | 2012-05-16 | 中国人民解放军军事医学科学院卫生学环境医学研究所 | 人源基因工程抗体trd109及其制备方法与应用 |
WO2011085574A1 (zh) * | 2010-01-15 | 2011-07-21 | 苏州工业园区晨健抗体组药物开发有限公司 | 全人TNFα单克隆抗体及其制备方法与应用 |
CN102167741A (zh) * | 2010-02-25 | 2011-08-31 | 百迈博药业有限公司 | 一种全人源抗TNF-α单克隆抗体、其制备方法及用途 |
WO2011103701A1 (zh) * | 2010-02-25 | 2011-09-01 | 百迈博药业有限公司 | 全人源抗TNF-α单克隆抗体、其制备方法及用途 |
US8597648B2 (en) | 2010-02-25 | 2013-12-03 | Shanghai Biomabs Pharmaceuticals Co., Ltd. | Fully human anti-TNF-alpha monoclonal antibody, preparation method and use thereof |
CN102167741B (zh) * | 2010-02-25 | 2014-05-14 | 上海百迈博制药有限公司 | 一种全人源抗TNF-α单克隆抗体、其制备方法及用途 |
Also Published As
Publication number | Publication date |
---|---|
CN100393748C (zh) | 2008-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7283806B2 (ja) | 抗pd-l1/vegf二機能性抗体およびその用途 | |
CN101426816B (zh) | 抗人白介素22的抗体及其用途 | |
CN1195779C (zh) | 抗人卵巢癌抗人cd3双特异性抗体 | |
CN1294148C (zh) | 环状单链三特异抗体 | |
US5639455A (en) | Immunosuppressant | |
WO2018050039A1 (zh) | 新的抗pd-1纳米抗体及其应用 | |
CN103342751B (zh) | 人粒细胞巨噬细胞集落刺激因子的抗体中和剂 | |
WO2017157334A1 (zh) | 抗pd-l1纳米抗体及其编码序列和用途 | |
CN102177178B (zh) | 抗il-12/il-23抗体 | |
CN108409860B (zh) | 抗人白细胞介素-4受体α单克隆抗体、其制备方法和应用 | |
RU2613422C2 (ru) | Антитело к blys | |
WO2018233574A1 (zh) | 一种抗pd-l1人源化纳米抗体及其应用 | |
CN102906111B (zh) | 特异性结合乙型肝炎病毒表面抗原的人抗体 | |
JP2007181458A (ja) | 組み換え三重足場ベースポリペプチド | |
CN102482352B (zh) | 抗il-17br的抗体 | |
CN112638946A (zh) | 抗il1rap抗体组合物 | |
CN116514971A (zh) | 一种抗lag-3的单克隆抗体、其抗原结合片段及其应用 | |
CN107840889A (zh) | 高亲和力的抗cd123抗体及其应用 | |
CN1200733C (zh) | 阻断淋巴毒素β与其受体结合的物质在制备药物中的应用 | |
EP4314073A1 (en) | Upar antibodies and fusion proteins with the same | |
CN103451218B (zh) | 一种新型细胞因子融合蛋白ip10单链抗体的制备方法 | |
CN1613874A (zh) | 全人源肿瘤坏死因子抗体,其制备方法以及药物组合物 | |
CN1187373C (zh) | 人源化抗血管内皮生长因子单克隆抗体及其制法和药物组合物 | |
CN101602809B (zh) | 具有抗炎作用的抗体靶向补体抑制物 | |
CN101407546A (zh) | 全人源抗人肿瘤坏死因子-α单链抗体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: Bibo Road, Pudong Zhangjiang hi tech park Shanghai city 201203 No. 5 Keyuan building 11 layer Patentee after: Shanghai CP Guojian Pharmaceutical Co., Ltd. Address before: Bibo Road, Pudong Zhangjiang hi tech park Shanghai city 201203 No. 5 Keyuan building 11 layer Patentee before: Zhongxin Guojian Pharmaceutical Co., Ltd., Shanghai |
|
ASS | Succession or assignment of patent right |
Owner name: ANTIBODIES NATIONAL ENGINEERING RESEARCH CENTER Free format text: FORMER OWNER: SHANGHAI CP GUOJIAN PHARMACEUTICAL CO., LTD. Effective date: 20110330 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 201203 11/F, KEYUAN BUILDING, NO. 5, BIBO ROAD, ZHANGJIANG HIGH-TECH. PARK,PUDONG, SHANGHAI TO: 201203 BUILDING 3, NO. 399, LIBING ROAD, ZHANGJIANG HIGH-TECH. PARK, PUDONG NEW DISTRICT, SHANGHAI |
|
TR01 | Transfer of patent right |
Effective date of registration: 20110330 Address after: Shanghai city 201203 libing road Zhangjiang High Tech Park of Pudong New Area No. 399 building 3 Patentee after: Antibodies National Engineering Research Center Address before: Bibo Road, Pudong Zhangjiang hi tech park Shanghai city 201203 No. 5 Keyuan building 11 layer Patentee before: Shanghai CP Guojian Pharmaceutical Co., Ltd. |
|
AV01 | Patent right actively abandoned |
Granted publication date: 20080611 Effective date of abandoning: 20140314 |
|
C20 | Patent right or utility model deemed to be abandoned or is abandoned |